published June 28, 2022
In this months newsletter we will be sharing the following updates: Update your details – ge
published March 7, 2022
In this month’s newsletter:Legs Out 2022 – join our national event!!Friday 11 March is Legs 1
published February 8, 2022
Lymphoma Australia have joined forces with the Cronulla Sharks and the Parramatta Eels to honour the legac
published January 3, 2022
Francesca is proudly supporting Lymphoma Australia this January with a limited edition Awareness Bracelet.
published September 13, 2021
The global community is addressing the ways the pandemic has harmed people living with lymphomas September
published September 1, 2021
On 1 September 2021, the CLL community is launching World CLL Day to give those affected by a diagnosis of CLL
published August 31, 2021
September is World Lymphoma Awareness month, so it is time to put lymphoma in the limelight! Throughout Sep
published August 5, 2021
Eligible patients can now access Yescarta through Royal Brisbane and Women’s Hospital, Brisbane and the Pete
published March 30, 2021
IMPORTANT Information for all Lymphoma/ CLL Australian patients receiving MabThera® (rituximab)   From
published February 24, 2021
Join our Ambassadors & get your Legs Out for Lymphoma this March – There is still time to sign up!
published February 17, 2021
Welcome to Frank Hegerty, former Australian rower, National Champion and a dual Olympian
published February 9, 2021
COVID-19 vaccinations and lymphoma/CLL – what does this mean for Australian patients? Professor Chan Cheah Q&A

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.